The diagnosis of a pancreatic or biliary tract lesion with cell-free DNA in pancreatic juice or bile

The diagnosis of a pancreatic or biliary tract lesion with cell-free DNA in pancreatic juice or bile - Diagnosis of a pancreatic or biliary tract lesion with cell-free DNA

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000044036

Enrollment

Registered

2021-04-26

Start date

2020-09-07

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pancreaticobiliary diseases

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: (1) Patients with pancreatic or bile duct stricture who require ERCP-related procedures (2) Patients who provided informed consent

Exclusion criteria

Exclusion criteria: (1) Patients in which appropriate samples are not obtained (2) Patients who are judged by the principal investigator to be inappropriate as research subjects

Design outcomes

Primary

Measure	Time frame
The sensitivity, specificity and accuracy of cfDNA analysis for malignancy	—

Countries

Japan

Contacts

Public ContactMasaki Kuwatani

Hokkaido University Hospital Division of Endoscopy

mkuwatan@med.hokudai.ac.jp011-716-1161

Outcome results